198 related articles for article (PubMed ID: 19487338)
1. Liver X receptors are negative regulators of cardiac hypertrophy via suppressing NF-kappaB signalling.
Wu S; Yin R; Ernest R; Li Y; Zhelyabovska O; Luo J; Yang Y; Yang Q
Cardiovasc Res; 2009 Oct; 84(1):119-26. PubMed ID: 19487338
[TBL] [Abstract][Full Text] [Related]
2. [Role of liver X receptors on cardiomyocyte hypertrophy].
Yin R; Wang MH; Wei YF; Li YQ; Dong YG
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Dec; 37(12):1119-23. PubMed ID: 20193185
[TBL] [Abstract][Full Text] [Related]
3. The liver X receptor agonist AZ876 protects against pathological cardiac hypertrophy and fibrosis without lipogenic side effects.
Cannon MV; Yu H; Candido WM; Dokter MM; Lindstedt EL; Silljé HH; van Gilst WH; de Boer RA
Eur J Heart Fail; 2015 Mar; 17(3):273-82. PubMed ID: 25684370
[TBL] [Abstract][Full Text] [Related]
4. Liver X receptor activation inhibits osteoclastogenesis by suppressing NF-κB activity and c-Fos induction and prevents inflammatory bone loss in mice.
Kim HJ; Yoon KA; Yoon HJ; Hong JM; Lee MJ; Lee IK; Kim SY
J Leukoc Biol; 2013 Jul; 94(1):99-107. PubMed ID: 23657115
[TBL] [Abstract][Full Text] [Related]
5. Suppression of beta-catenin signaling by liver X receptor ligands.
Uno S; Endo K; Jeong Y; Kawana K; Miyachi H; Hashimoto Y; Makishima M
Biochem Pharmacol; 2009 Jan; 77(2):186-95. PubMed ID: 18983830
[TBL] [Abstract][Full Text] [Related]
6. Liver X receptor agonists suppress vascular smooth muscle cell proliferation and inhibit neointima formation in balloon-injured rat carotid arteries.
Blaschke F; Leppanen O; Takata Y; Caglayan E; Liu J; Fishbein MC; Kappert K; Nakayama KI; Collins AR; Fleck E; Hsueh WA; Law RE; Bruemmer D
Circ Res; 2004 Dec; 95(12):e110-23. PubMed ID: 15539633
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effect of peroxisome proliferator activated receptor-gamma and liver X receptor-alpha in the regulation of inflammation in macrophages.
Piraino G; Cook JA; O'Connor M; Hake PW; Burroughs TJ; Teti D; Zingarelli B
Shock; 2006 Aug; 26(2):146-53. PubMed ID: 16878022
[TBL] [Abstract][Full Text] [Related]
8. Smad Nuclear Interacting Protein 1 Acts as a Protective Regulator of Pressure Overload-Induced Pathological Cardiac Hypertrophy.
Lu YY; Xu DC; Zhao YF; Zhu GF; Zhu MY; Liu WJ; Yu XJ; Chen W; Liu Z; Xu YW
J Am Heart Assoc; 2016 Oct; 5(11):. PubMed ID: 27912208
[TBL] [Abstract][Full Text] [Related]
9. Liver X receptor (LXR)-beta regulation in LXRalpha-deficient mice: implications for therapeutic targeting.
Quinet EM; Savio DA; Halpern AR; Chen L; Schuster GU; Gustafsson JA; Basso MD; Nambi P
Mol Pharmacol; 2006 Oct; 70(4):1340-9. PubMed ID: 16825483
[TBL] [Abstract][Full Text] [Related]
10. Activation of liver X receptors prevents statin-induced death of 3T3-L1 preadipocytes.
Madsen L; Petersen RK; Steffensen KR; Pedersen LM; Hallenborg P; Ma T; Frøyland L; Døskeland SO; Gustafsson JA; Kristiansen K
J Biol Chem; 2008 Aug; 283(33):22723-36. PubMed ID: 18487205
[TBL] [Abstract][Full Text] [Related]
11. A nuclear receptor corepressor-dependent pathway mediates suppression of cytokine-induced C-reactive protein gene expression by liver X receptor.
Blaschke F; Takata Y; Caglayan E; Collins A; Tontonoz P; Hsueh WA; Tangirala RK
Circ Res; 2006 Dec; 99(12):e88-99. PubMed ID: 17110595
[TBL] [Abstract][Full Text] [Related]
12. Liver X receptor and retinoid X receptor agonists inhibit inflammatory responses of microglia and astrocytes.
Zhang-Gandhi CX; Drew PD
J Neuroimmunol; 2007 Feb; 183(1-2):50-9. PubMed ID: 17175031
[TBL] [Abstract][Full Text] [Related]
13. Interferon regulatory factor 7 functions as a novel negative regulator of pathological cardiac hypertrophy.
Jiang DS; Liu Y; Zhou H; Zhang Y; Zhang XD; Zhang XF; Chen K; Gao L; Peng J; Gong H; Chen Y; Yang Q; Liu PP; Fan GC; Zou Y; Li H
Hypertension; 2014 Apr; 63(4):713-22. PubMed ID: 24396025
[TBL] [Abstract][Full Text] [Related]
14. Liver X receptors regulate dendritic cell phenotype and function through blocked induction of the actin-bundling protein fascin.
Geyeregger R; Zeyda M; Bauer W; Kriehuber E; Säemann MD; Zlabinger GJ; Maurer D; Stulnig TM
Blood; 2007 May; 109(10):4288-95. PubMed ID: 17255360
[TBL] [Abstract][Full Text] [Related]
15. LXRα represses LPS-induced inflammatory responses by competing with IRF3 for GRIP1 in Kupffer cells.
Miao CM; He K; Li PZ; Liu ZJ; Zhu XW; Ou ZB; Ruan XZ; Gong JP; Liu CA
Int Immunopharmacol; 2016 Jun; 35():272-279. PubMed ID: 27085678
[TBL] [Abstract][Full Text] [Related]
16. Intestine-specific regulation of PPARalpha gene transcription by liver X receptors.
Colin S; Bourguignon E; Boullay AB; Tousaint JJ; Huet S; Caira F; Staels B; Lestavel S; Lobaccaro JM; Delerive P
Endocrinology; 2008 Oct; 149(10):5128-35. PubMed ID: 18566121
[TBL] [Abstract][Full Text] [Related]
17. Liver-X-receptor activator prevents homocysteine-induced production of IgG antibodies from murine B lymphocytes via the ROS-NF-kappaB pathway.
Chang L; Zhang Z; Li W; Dai J; Guan Y; Wang X
Biochem Biophys Res Commun; 2007 Jun; 357(3):772-8. PubMed ID: 17445767
[TBL] [Abstract][Full Text] [Related]
18. Activation of liver X receptors with T0901317 attenuates cardiac hypertrophy in vivo.
Kuipers I; Li J; Vreeswijk-Baudoin I; Koster J; van der Harst P; Silljé HH; Kuipers F; van Veldhuisen DJ; van Gilst WH; de Boer RA
Eur J Heart Fail; 2010 Oct; 12(10):1042-50. PubMed ID: 20587624
[TBL] [Abstract][Full Text] [Related]
19. Liver X receptor agonism promotes articular inflammation in murine collagen-induced arthritis.
Asquith DL; Miller AM; Hueber AJ; McKinnon HJ; Sattar N; Graham GJ; McInnes IB
Arthritis Rheum; 2009 Sep; 60(9):2655-65. PubMed ID: 19714646
[TBL] [Abstract][Full Text] [Related]
20. Effects of liver X receptor agonist treatment on pulmonary inflammation and host defense.
Smoak K; Madenspacher J; Jeyaseelan S; Williams B; Dixon D; Poch KR; Nick JA; Worthen GS; Fessler MB
J Immunol; 2008 Mar; 180(5):3305-12. PubMed ID: 18292555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
